Meitheal Pharmaceuticals, Inc.’s Post

𝐆𝐲𝐧𝐞𝐜𝐨𝐥𝐨𝐠𝐲 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟏. 𝐆𝐥𝐨𝐛𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 Download Sample Report Now: https://lnkd.in/dQXCG-49 #Gynecologydrugs, also known as reproductive #health drugs, imply medications for illnesses that affect the reproductive system, thereby enclosing care for women during as well as after pregnancy. Such drugs treat numerous #gynecological diseases that are likely to impact ovaries, uterus, and appendages. Primary #therapeutic categories are inclusive of non-hormonal and hormonal therapy. Hormonal therapy implies treatments adding, blocking, or removing #hormones to impede the #growth of cancer cells, whereas non-hormonal therapy involves the usage of anti-inflammatory and anti-infective agents, moisturizers, lubricants, and antidepressants. Apart from treating gynecological cancers, gynecology drugs act as menstrual disorders medications, hormonal gynecological treatments, fertility-enhancing #pharmaceuticals, and pregnancy-related medications as well. By Therapeutics Hormonal Therapy Non-hormonal Therapy By Indication Gynecology Cancers Menopausal Disorder Polycystic Ovary Syndrome Contraception Other Indications By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies The List of Companies: 1. Eli Lilly and Company 2. Pfizer Inc. 3. Merck & Co., Inc. 4. Amgen Inc. 5. AstraZeneca 6. F. Hoffmann-La Roche Ltd. 7. Allergan Plc. 8. Bayer AG 9. Abbott 10. AbbVie

Strength isn't just a measure; it's a journey. Join Galaxy Pharma in navigating the challenges of infertility with resilience and hope.  #WellnessJourney #HealthIsHappines #galaxypharma #pharma #medicine #wellbeing #humanbody #infertility #gynecology #oncology #obstetrics  #health #healthylife #pharmaceutical

“Our shared goal is to offer women a more comfortable and efficient gynaecological experience, reducing the cases of pain associated with IUD procedures.” The traditional ‘forceps-like’ tenaculum is a big reason for the pain, discomfort and bleeding women experience during uterine procedures such as IUD insertion. Now Aspivix - makers of a gentler alternative to the tenaculum - is teaming up with Bayer | Pharmaceuticals (Schweiz) AG in Switzerland to reduce the pain of gynaecological procedures. cc. Women by Bayer https://lnkd.in/ecihUEkE

Preparatory drugs used before the sickle cell treatment can cause infertility. But Vertex Pharmaceuticals can’t currently help patients covered by Medicaid pay for important services like freezing eggs. ...“Even though Medicaid and most other insurers already deny Americans with [sickle cell] fertility coverage, the federal government, through [the inspector general]’s refusal to issue a favorable advisory opinion, has effectively prohibited those patients from receiving free fertility services from others — leaving them with the Hobson’s choice between undergoing a potentially curative treatment or becoming biological parents,” the suit states..... . #raredisease #rarediseases #sicklecelldisease #fertility #righttopreserve #acccess #genetherapy #cellandgegetherapy #advancedtherapies #regenerativemedicine #biotech #biotechnology #fertilitycoverage #infertility #lifescience #lifesciences #writtenopinion #geneediting #chemotherapy #celltherapy #Casgevy #pharma #pharmaceuticals #equitableaccess

🌟 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐍𝐚𝐮𝐬𝐞𝐚 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞: 𝐈𝐦𝐩𝐫𝐨𝐯𝐢𝐧𝐠 𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐨𝐟 𝐋𝐢𝐟𝐞 𝐟𝐨𝐫 𝐏𝐚𝐭𝐢𝐞𝐧𝐭𝐬! 🌟 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gtuBhZyk Nausea can significantly impact individuals' well-being, whether due to motion sickness, pregnancy, chemotherapy, or other causes. Join us as we explore the latest developments in the Nausea Medicine Market, offering hope and relief to those affected by this challenging symptom. 💊💫 🔬 Innovative Therapies: From traditional antiemetics to novel medications and formulations, the Nausea Medicine Market continues to evolve, providing healthcare providers with a diverse range of options to address nausea and vomiting effectively. 🌍 Global Impact: Nausea is a universal experience, affecting individuals of all ages and backgrounds worldwide. The Nausea Medicine Market plays a crucial role in improving quality of life for patients across the globe, regardless of the underlying cause of their symptoms. 💡 Patient-Centered Care: With a focus on patient-centered care, healthcare providers are increasingly tailoring treatment approaches to meet individuals' unique needs and preferences, ensuring that patients receive the most appropriate and effective nausea management strategies. 🚀 Research and Development: Ongoing research and development efforts in the pharmaceutical industry aim to identify new therapeutic targets, optimize existing medications, and develop innovative delivery systems to enhance the efficacy and tolerability of nausea medicines. #Company Merck Group Sanofi TESARO, Inc. Roche Pfizer GSK ANI Pharmaceuticals, Inc. #Type • Antacids • Antagonists • Steroids • Others #Application • Hospital • Clinics • Pharmaceutical Companies #follow Stringent Datalytics - Healthcare #NauseaMedicine #HealthcareInnovation #PatientCare #QualityofLife #HealthForAll

News has been abuzz with Ozempic and fertility—but what about other life-changing prescription drugs? In today’s What the Fertility, in collaboration with our partner RMA of New York, we look at spironolactone use. Spironolactone, a diuretic for high blood pressure, is often prescribed to reproductive-aged women because of its anti-androgen properties that help symptoms associated with PCOS—acne/excessive hair growth—by reducing testosterone levels. It’s typical to take patients off the meds when they want to get pregnant because of the concern that lowering male hormone levels could cause a “feminization” of potential male embryos. It can also cause irregular menstrual cycles. But what about egg freezing? Could it affect the number of mature eggs retrieved Should patients go off of it first? The reason patients are hesitant to go off the medication when they don’t have to is that it’s such a helpful treatment for what can be painful side effects—both emotionally and physically. So endocrinologists at RMA of New York Dr. Atoosa Ghofranian and Dr. Kimberley Thornton (https://lnkd.in/eGeHtrkn) went to work finding out if you really need to come off spironolactone before freezing your eggs with a retrospective cohort study evaluating oocyte yield and maturation rates in patients on the drug. The conclusion? They found no difference in the number of eggs retrieved or number of mature eggs that were frozen between patients who continued spironolactone and those who didn’t. There are some limitations but so far the findings have been reassuring. The next step will be to study what happens when they use the eggs. If you’re on spironolactone and want to keep taking it while freezing your eggs, it looks like you’ll be OK to do so with the blessing from your doctor. (Interestingly, the REIs first came to study this topic after working with transgender men concerned that being on high levels of testosterone could affect egg freezing and were curious what would happen if the reverse happened.) Sources: https://lnkd.in/e7gVdvrE https://lnkd.in/eD8YiEK8

The global Infertility Treatment Drugs market was valued at US$ 5586 million in 2023 and is anticipated to reach US$ 9394 million by 2030 witnessing a CAGR of 7.8% during the forecast period 20242030. #GlobalInfertilityTreatmentDrugsMarket #InfertilityTreatment #FertilityDrugs #Gonadotropins #AntiEstrogens #MaleInfertility #FemaleInfertility #PharmaceuticalIndustry #MarketGrowth #MedicalAdvancements

Check out the latest report from IMIR Market Research Pvt. Ltd. on the 𝗠𝗼𝘂𝘁𝗵 𝗨𝗹𝗰𝗲𝗿𝘀 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁 Outlook and Geography Forecast till 2028 Don't miss out on this opportunity to stay informed about the latest trends in the industry. Mouth Ulcers Treatment Market Size, Share & Trends Analysis Report By Drug Class (Analgesics and Corticosteroids, Antihistamine, Antimicrobial, Anesthetic), By Formulation Type (Sprays, Mouthwash, Gels, Lozenges), By Indication (Aphthous Stomatitis, Oral Lichen Planus, Others), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2032 📚 𝐆𝐞𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 𝐝𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐩𝐫𝐢𝐜𝐞:👇 https://lnkd.in/drFqdsHU 📚𝐓𝐨𝐩 𝐌𝐨𝐫𝐞 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐀𝐫𝐞::👇 3Mcompany Apotex Inc. Blairex Laboratories, Inc. Blistex Inc. Bristol-Myers Squibb Pharma Company Church & Dwight Co., Inc. Colgate-Palmolive Dr. Reddy's Laboratories EPIEN Medical, Inc.. GSK Guilin Sanjin Pharmaceutical Co., Ltd ICPA HEALTH PRODUCTS LTD. Intas Pharmaceuticals. LloydsPharmacy Patterson Dental Supply, Inc. Pfizer Prince Care Pharma Pvt.Ltd. RAPTAKOS BRETT AND COMPANY LIMITED Reckitt Sinclair Pharma Korea STADA Arzneimittel AG / ADR SUNSTAR SUISSE SA SUCURSAL EN ESPAÑA Taro Pharmaceutical Industries. #ulcer #diabetes #cancer #health #stroke #herpes #healthylifestyle #pregnancy #stomach #weightloss #epilepsy #ulcerativecolitis #kidney #hiv #hpv #hepatitis #hypertension #infertility #doctor #pepticulcer #asthma #beauty #erection #fever #stomachulcer #medicine #lowspermcount #medical #healthy #wound

Why Penicillins cannot pass blood brain barrier but can pass placenta ? And why doctors prescribe it during pregnancy although it can pass through placenta barrier ? When Penicillins are affected by blood PH , it became ionized which inhibits passing blood brain barrier , it passes only in case of manningites ( in that case there is leakage in cerebral cell wall because of the inflammation , which allows penicillins to pass through ). MOA of Penicillins is to bind to specific enzyme in bacteria cell wall called transpeptidase enz. ( or PBP: Penicillin Binding Proteins ) which inhibit cell wall building leading to cell wall rupture. So , in case of placenta , Penicillins can cross placenta barrier but not teratogenic ( so it is safe for fetus during pregnancy ) because in healthy people , there is no transpeptidase enzyme in human cells but in bacterial cells only ). If you find those notes are beneficial to you, just like , share or at least follow me to find similar content. #pharma #pharmacology #pharmacist #learn_pharma_with_Mike

𝐔𝐫𝐢𝐧𝐚𝐫𝐲 𝐓𝐫𝐚𝐜𝐭 𝐈𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐢𝐳𝐞, 𝐒𝐡𝐚𝐫𝐞 & 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟑𝟒 ▶𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅: https://lnkd.in/dFVEYHs2 The Global Urinary Tract Infection (UTI) Therapeutics market is expected to surpass USD 10.6 billion by 2031, growing from USD 7.4 billion in 2021 at a CAGR of 3.7% over the period from 2021 to 2031. UTIs are prevalent, especially among women due to factors like menstruation, pregnancy, and certain birth control methods. Individuals with diabetes are also at increased risk, as diabetes can exacerbate urological issues and elevate the likelihood of UTIs and bladder complications by affecting blood flow, nerve function, and sensory processes. The market growth is driven by rising cases of diabetes and kidney stones, which contribute to the increasing demand for UTI therapeutics globally.   𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: ▶𝐁𝐲 𝐈𝐧𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧: Complicated UTI, Uncomplicated UTI, Other. ▶𝐁𝐲 𝐃𝐫𝐮𝐠 𝐓𝐲𝐩𝐞: Quinolones, Cephalosporin, Azoles, Amphotericin B, Nitro furans, Other. ▶𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧: North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA). 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐜𝐨𝐯𝐞𝐫𝐞𝐝: Bayer, Pfizer, GSK, Bristol Myers Squibb, The Janssen Pharmaceutical Companies of Johnson & Johnson, Lupin, Merck, Almirall. #UTI #UrinaryTractInfection #UTITherapeutics #UTITreatment #UTIAwareness #AntibioticResistance #UTIPrevention #UTIDiagnostics #UTISymptoms #WomenHealth #MenHealth #InfectiousDiseases #UrinaryHealth #UTIPatientCare #UTIEpidemiology #HealthcareInnovation #GlobalHealth #Pharmaceuticals #MedicalResearch #PublicHealth